Darmstädter Strasse 34-36
Zwingenberg 64673
Germany
49 62 51 9331 0
https://www.brain-biotech.com
Settore/i:
Settore:
Impiegati a tempo pieno: 316
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Adriaan Moelker | Chairman of the Management Board & CEO | 620k | N/D | N/D |
Mr. Ulrich Putsch | Co-Founder | N/D | N/D | N/D |
Mr. Michael Schneiders | CFO & Member of Management Board | N/D | N/D | 1970 |
Dr. Ute Dechert | VP of HR & Processes | N/D | N/D | 1961 |
Dr. Jurgen Eck | Consultant | N/D | N/D | 1962 |
Dr. Martin Langer | MD & Exec. VP | N/D | N/D | 1965 |
Thomas Deichmann | Head of PR | N/D | N/D | N/D |
Dr. Alexander Pelzer | VP and Head of R&D - Zwingenberg | N/D | N/D | 1986 |
Mr. Robbert Michael Hoekstra | Head of Group Fin. | N/D | N/D | 1978 |
Mr. Paul Scholz | Technical Lead of Genome Editing Devel. | N/D | N/D | N/D |
BRAIN Biotech AG offers Bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates in two segments, BioScience and BioIndustrial. It offers enzymes and biocatalysts to produce food and beverages, wound care preparations or lubricants, and production of starch and bioethanol; bioactive natural compounds for product developments in the food, animal feed, skin care, chemical, and cosmetics industries; and microorganisms as the functional biomass for optimized industrial production processes, recycling of the greenhouse gas CO2 as an industrial raw material, and urban and green mining for extraction of precious and rare earth metals. The company also offers R&D services for contract research for product development and innovative solutions in the categories of enzymes, microbial production strains, and bioprocesses. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.
L'ISS Governance QualityScore di BRAIN Biotech AG al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.